GCM
ABBV icon

GKV Capital Management’s AbbVie ABBV Stock Holding History

GKV Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.94M Buy
11,679
+530
+5% +$114K 0.95% 32
2026
Q1 		$2.42M Sell
11,149
-471
-4% -$104K 0.91% 34
2025
Q4 		$2.66M Buy
11,620
+400
+4% +$91.1K 0.99% 26
2025
Q3 		$2.6M Buy
11,220
+500
+5% +$102K 1.03% 25
2025
Q2 		$1.99M Buy
10,720
+4,840
+82% +$900K 0.88% 30
2025
Q1 		$1.23M Buy
5,880
+2,900
+97% +$564K 0.61% 40
2024
Q4 		$530K Buy
+2,980
New +$548K 0.22% 64

Other funds holding ABBV

Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

GKV Capital Management's ABBV Position: Q2 2026 in Review

GKV Capital Management increased its AbbVie (ABBV) stake by 4.8% in Q2 2026, buying an estimated $114K and bringing the position to 11,679 shares worth $2.94M. The position accounts for 0.95% of the portfolio, ranked #32.

GKV Capital Management first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 2,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • GKV Capital Management held 11,679 shares of AbbVie worth $2.94M as of Q2 2026.
  • GKV Capital Management bought 530 AbbVie shares in Q2 2026, an estimated $114K.
  • AbbVie made up 0.95% of GKV Capital Management's portfolio in Q2 2026, its #32 holding.
  • GKV Capital Management first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
  • 2,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on GKV Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.